134 related articles for article (PubMed ID: 30602951)
1. An eight cytokine signature identified from peripheral blood serves as a fingerprint for hepatocellular cancer diagnosis.
Shen J; Wu H; Peng N; Cai J
Afr Health Sci; 2018 Jun; 18(2):260-266. PubMed ID: 30602951
[TBL] [Abstract][Full Text] [Related]
2. Role of several cytokines and adhesion molecules in the diagnosis and prediction of survival of hepatocellular carcinoma.
Iliaz R; Akyuz U; Tekin D; Serilmez M; Evirgen S; Cavus B; Soydinc H; Duranyildiz D; Karaca C; Demir K; Besisik F; Kaymakoglu S; Akyuz F
Arab J Gastroenterol; 2016 Dec; 17(4):164-167. PubMed ID: 27916547
[TBL] [Abstract][Full Text] [Related]
3. Change in inflammatory cytokine profiles after transarterial chemotherapy in patients with hepatocellular carcinoma.
Kim MJ; Jang JW; Oh BS; Kwon JH; Chung KW; Jung HS; Jekarl DW; Lee S
Cytokine; 2013 Nov; 64(2):516-22. PubMed ID: 24035756
[TBL] [Abstract][Full Text] [Related]
4. Inflammatory patterns in plasma associate with hepatocellular carcinoma development in cured hepatitis C cirrhotic patients.
Owusu Sekyere S; Port K; Deterding K; Cornberg M; Wedemeyer H
United European Gastroenterol J; 2021 May; 9(4):486-496. PubMed ID: 33349201
[TBL] [Abstract][Full Text] [Related]
5. Peripheral blood microvesicles are potential biomarkers for hepatocellular carcinoma.
Wang W; Li H; Zhou Y; Jie S
Cancer Biomark; 2013; 13(5):351-7. PubMed ID: 24440975
[TBL] [Abstract][Full Text] [Related]
6. PIVKA-II serves as a potential biomarker that complements AFP for the diagnosis of hepatocellular carcinoma.
Feng H; Li B; Li Z; Wei Q; Ren L
BMC Cancer; 2021 Apr; 21(1):401. PubMed ID: 33849479
[TBL] [Abstract][Full Text] [Related]
7. Changes of plasma cytokines and chemokines expression level in nasopharyngeal carcinoma patients after treatment with definitive intensity-modulated radiotherapy (IMRT).
Jin YB; Zhang GY; Lin KR; Chen XP; Cui JH; Wang YJ; Luo W
PLoS One; 2017; 12(2):e0172264. PubMed ID: 28207826
[TBL] [Abstract][Full Text] [Related]
8. Serum levels of chemokines CCL4 and CCL5 in cirrhotic patients indicate the presence of hepatocellular carcinoma.
Sadeghi M; Lahdou I; Oweira H; Daniel V; Terness P; Schmidt J; Weiss KH; Longerich T; Schemmer P; Opelz G; Mehrabi A
Br J Cancer; 2015 Sep; 113(5):756-62. PubMed ID: 26270232
[TBL] [Abstract][Full Text] [Related]
9. Blood gene signature for early hepatocellular carcinoma detection in patients with chronic hepatitis B.
Omar H; Lim CR; Chao S; Lee MM; Bong CW; Ooi EJ; Yu CG; Tan SS; Abu Hassan MR; Menon J; Muthukaruppan R; Singh M; Nik Abdullah NA; Ooi BP; Ding RP; Low EJ; Tan F; Novak D; Harris DF; Yang H; Merican I; Liew CC
J Clin Gastroenterol; 2015 Feb; 49(2):150-7. PubMed ID: 25569223
[TBL] [Abstract][Full Text] [Related]
10. Dysregulation of serum microRNA-574-3p and its clinical significance in hepatocellular carcinoma.
Shen X; Xue Y; Cong H; Wang X; Ju S
Ann Clin Biochem; 2018 Jul; 55(4):478-484. PubMed ID: 29065698
[TBL] [Abstract][Full Text] [Related]
11. Cytokine levels contribute to the pathogenesis of minimal hepatic encephalopathy in patients with hepatocellular carcinoma via STAT3 activation.
Wu H; Li N; Jin R; Meng Q; Chen P; Zhao G; Wang R; Li L; Li W
Sci Rep; 2016 Jan; 6():18528. PubMed ID: 26757951
[TBL] [Abstract][Full Text] [Related]
12. Serum cytokine profiles predict survival benefits in patients with advanced hepatocellular carcinoma treated with sorafenib: a retrospective cohort study.
Hayashi T; Yamashita T; Terashima T; Suda T; Okada H; Asahina Y; Hayashi T; Hara Y; Nio K; Sunagozaka H; Takatori H; Arai K; Sakai Y; Yamashita T; Mizukoshi E; Honda M; Kaneko S
BMC Cancer; 2017 Dec; 17(1):870. PubMed ID: 29258450
[TBL] [Abstract][Full Text] [Related]
13. Application of serum protein fingerprinting coupled with artificial neural network model in diagnosis of hepatocellular carcinoma.
Wang JX; Zhang B; Yu JK; Liu J; Yang MQ; Zheng S
Chin Med J (Engl); 2005 Aug; 118(15):1278-84. PubMed ID: 16117882
[TBL] [Abstract][Full Text] [Related]
14. Role of relevant immune-modulators and cytokines in hepatocellular carcinoma and premalignant hepatic lesions.
Zekri AN; El Deeb S; Bahnassy AA; Badr AM; Abdellateif MS; Esmat G; Salama H; Mohanad M; El-Dien AE; Rabah S; Abd Elkader A
World J Gastroenterol; 2018 Mar; 24(11):1228-1238. PubMed ID: 29568203
[TBL] [Abstract][Full Text] [Related]
15. Multi-parameter gene expression profiling of peripheral blood for early detection of hepatocellular carcinoma.
Xie H; Xue YQ; Liu P; Zhang PJ; Tian ST; Yang Z; Guo Z; Wang HM
World J Gastroenterol; 2018 Jan; 24(3):371-378. PubMed ID: 29391759
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic specificity and sensitivity of PIVKAII, GP3, CSTB, SCCA1 and HGF for the diagnosis of hepatocellular carcinoma in patients with alcoholic liver cirrhosis.
Unić A; Derek L; Duvnjak M; Patrlj L; Rakić M; Kujundžić M; Renjić V; Štoković N; Dinjar P; Jukic A; Grgurević I
Ann Clin Biochem; 2018 May; 55(3):355-362. PubMed ID: 28766361
[TBL] [Abstract][Full Text] [Related]
17. Multi-analyte analysis of cytokines that predict outcomes in patients with hepatocellular carcinoma treated with radiotherapy.
Cha H; Lee EJ; Seong J
World J Gastroenterol; 2017 Mar; 23(11):2077-2085. PubMed ID: 28373775
[TBL] [Abstract][Full Text] [Related]
18. Higher serum interleukin-17A levels as a potential biomarker for predicting early disease progression in patients with hepatitis B virus-associated advanced hepatocellular carcinoma treated with sorafenib.
Cho HJ; Kim SS; Nam JS; Oh MJ; Kang DR; Kim JK; Lee JH; Kim B; Yang MJ; Hwang JC; Lim SG; Shin SJ; Lee KM; Yoo BM; Lee KJ; Cho SW; Cheong JY
Cytokine; 2017 Jul; 95():118-125. PubMed ID: 28260649
[TBL] [Abstract][Full Text] [Related]
19. Serum biomarkers for early detection of hepatocellular carcinoma associated with HCV infection in egyptian patients.
Zekri AR; Youssef AS; Bakr YM; Gabr RM; El-Rouby MN; Hammad I; Ahmed EA; Marzouk HA; Nabil MM; Hamed HA; Aly YH; Zachariah KS; Esmat G
Asian Pac J Cancer Prev; 2015; 16(3):1281-7. PubMed ID: 25735368
[TBL] [Abstract][Full Text] [Related]
20. Assessment of prognostic and diagnostic value of some biomarkers in hepatocellular carcinoma.
Çavuş B; Akyuz F; İliaz R; Akyuz U; Duranyıldız D; Serilmez M; Tekin D; Evirgen S; Karaca Ç; Demir K; Beşışık F; Kaymakoğlu S
Exp Oncol; 2020 Sep; 42(3):208-214. PubMed ID: 32996733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
